SCHEMBL1631573

SCHEMBL1631573

CCN(CC)C(=O)c1cc(-c2ccnn2-c2ccccc2Cl)c(OC)cc1OC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 5/20 0.52
NPC1 O15118 1/20 0.43
ALDH1A1 P00352 1/20 0.43
HPGD P15428 1/20 0.43
ALOX15 P16050 1/20 0.43
RAB9A P51151 1/20 0.43
HSD17B10 Q99714 1/20 0.43
HSP90AA1 P07900 3/20 0.41
HCRTR1 O43613 4/20 0.40
HCRTR2 O43614 4/20 0.40
CYP2C9 P11712 2/20 0.40
NR3C2 P08235 2/20 0.40
TSHR P16473 1/20 0.39
MAPT P10636 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
SLC16A3 O15427 1/20 0.36
SLC16A1 P53985 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1630247 0.84 HSP90AA1 (0.56) PDE11AALDH1A1HSP90AA1HCRTR1HCRTR2
SCHEMBL1630236 0.78 ALDH1A1 (0.41) PDE11AALDH1A1HSP90AA1CYP2C9TSHR
SCHEMBL1630004 0.78 HSP90AA1 (0.38) PDE11AALDH1A1RAB9AHSP90AA1NR3C2
SCHEMBL1628606 0.77 HSP90AA1 (0.41) PDE11ANPC1ALDH1A1HPGDRAB9A
SCHEMBL1629896 0.77 KCNN4 (0.44) HSP90AA1NR3C2MAPTSLC16A3SLC16A1
SCHEMBL1629564 0.77 HSP90AA1 (0.44) ALDH1A1HSP90AA1NR3C2MAPTSLC16A3
SCHEMBL1630418 0.76 HSP90AA1 (0.41) PDE11AALDH1A1HSD17B10HSP90AA1NR3C2
SCHEMBL1630297 0.76 HSP90AA1 (0.41) NPC1ALDH1A1HPGDRAB9AHSP90AA1
SCHEMBL1630560 0.76 HSP90AA1 (0.40) ALDH1A1HPGDHSP90AA1NR3C2MAPT
SCHEMBL1219165 0.75 HSP90AA1 (0.40) ALDH1A1HSD17B10HSP90AA1NR3C2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP disclosed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P PDE11A 4692/4885NPC1 855/4885ALDH1A1 777/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.